Patient Perceptions of Diabetes Guideline Frameworks for Individualizing Glycemic Targets

Abstract

IMPORTANCE Diabetes guidelines recommend considering specific factors, such as diabetes duration and life expectancy, to individualize treatment in older adults. These individualized glycemic targets inform decisions on whether to intensify or deintensify medication treatment plans. How older adults with diabetes perceive these factors used to individualize glycemic targets is unknown.OBJECTIVES To examine how older adults perceive factors used in diabetes guidelines for individualizing glycemic targets. DESIGN, SETTING, AND PARTICIPANTSA cross-sectional national survey was conducted from December 13, 2018, to January 3, 2019, of a nationally representative, probability-based online survey panel (KnowledgePanel). A total of 1364 KnowledgePanel members who were 65 years or older and had type 2 diabetes were invited to participate in the survey; 836 (61.3%) responded, and 818 (60.0%) completed the survey. MAIN OUTCOMES AND MEASURESThe study randomized participants to 2 vignettes: one about adding and the other about removing diabetes medications from treatment plans. Participants rated the importance of 7 factors (diabetes duration, established diabetes complications, other health conditions, life expectancy, risk of adverse effects, cost, and treatment effort) in these treatment decisions using binary (yes/no) responses and the best-worst scaling method to quantify the factors' relative importance. All participants then answered questions on how different levels of each factor were associated with aggressiveness of diabetes treatment. RESULTSThe sample included 818 participants (mean [SD] age, 74.0 [6.8] years; 469 [53.7%] male; and 668 [67.7%] white). A total of 410 participants answered questions about adding medicine, whereas 408 participants answered questions about stopping medicine. Of the 7 factors to consider for adding a diabetes medication to the treatment plan, the number who deemed each factor important ranged from 197 (45.6%) to 263 (62.8%). In contrast, these same factors were considered important by only 29 (8.4%) to 146 (37.7%) of participants when deciding to stop use of a diabetes medication. In both decisions, participants perceived the risk of adverse effects as the most important factor (relative importance was 22.8 for adding a medicine and 25.0 for stopping a medicine on a ratio scale in which, for each decision, the relative importance of the 7 factors adds up to 100, with 0 indicating complete indifference and 100 complete priority). In contrast to current guideline recommendations, most participants believed that patients with longer disease duration (498 [60.1%]), more established complications (632 [75.6%]), and greater number of other health conditions (545 [67.5%]) should receive more aggressive diabetes treatment.CONCLUSIONS AND RELEVANCE Many older adults do not place high importance on factors recommended by guidelines to individualize diabetes treatment, especially when deciding to stop use of diabetes medications. Moreover, when considering treatment aggressiveness, many older ad...

Patient Preferences for Pharmacological Diabetes Treatment Among People with Diabetes in Spain: A Discrete Choice Experiment

“…In our analysis, hypoglycaemia obtained a relative importance with respect to the rest of the attributes, being in line with what has been reported by other studies, in which patients with type 2 diabetes mellitus (T2DM) indicated that the most important factor in both initiating and discontinuing treatment is the risk of suffering adverse effects [40].…”

Association between triglyceride glucose index and coronary artery disease with type 2 diabetes mellitus in middle-aged and elderly people

“…All patients were assigned into the following subgroups according to age and sex: middle-aged (40≤ age <60 years, n = 821) and elderly (age ≥60 years, n = 844) subgroups and male (n = 671) and female (n = 994) subgroups. The inclusion criteria were as follows: age ≥40 years, CAD [ 10 ] (unstable angina; non-ST elevation myocardial infarction; ST-elevation myocardial infarction; and coronary angiography showing the stenosis at least or more than 50% in 1 or more of the left main, left anterior descending, left circumfex, right coronary, or their main branches), and T2DM [ 11 ] (diagnosed according to the American Diabetes Association of diabetes guidelines). The major exclusion criteria included recent acute coronary syndrome, type 1 diabetes or secondary diabetes, connective tissue disease, severe valvular heart disease, constrictive pericarditis, hypertrophic cardiomyopathy, clinical history of malignant cancer, and insufficient medical record for TyG index calculation.…”

Hypoglycemia Communication in Primary Care Visits for Patients with Diabetes

“…[41][42][43] Further, patients with diabetes prioritize addressing symptomatic concerns in complex visits and rate the risk for adverse drug events as the most important factor for choosing a glycemic target. [44][45][46][47][48] The anticipatory guidance for hypoglycemia prevention provided by clinicians in this study was generally consistent with guidelines, although incomplete. Areas that were frequently omitted were treatment of hypoglycemic events and avoidance of driving with hypoglycemia.…”